The World Market for Transdermal Drug Delivery

September 2012 | 100 pages | ID: WF0CC47DA55EN
Kalorama Information

Abstracts

Transdermal (and related transmucosal) drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. There is no potential limit for the therapeutic area for development of transdermal systems. Some therapeutic areas stand out, including sex hormones and pain management, due to the successful combination of the individual drug molecules and available product technologies. The potential benefits that may be achieved using transdermal delivery include continuous, controlled release and absorption of medication into the body, avoiding presystemic metabolism that may occur following oral dosing, including both intestinal and hepatic first-pass metabolism, improving patient compliance by offering more convenient dosing regimens , such as once or twice weekly dosing, and the ability to quickly discontinue treatment by removal of the system.

This report, World Markets for Transdermal Drug Delivery is a comprehensive look at the transdermal/transmucosal drug delivery market is divided into two sections. The first section encompasses the pharmaceutical products that utilize the drug delivery technology. The second section encompasses drug delivery technology and the revenues earned from licensing that technology. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales for products utilizing that technology.

This market is divided into two segments:

• Market Size and Forecast for Transdermal Drug Delivery
• Market Size and Forecast for Transmucosal Drug Delivery
• Market Breakout by Region (US, Europe, Japan, ROW)
• Review of Products on the Market
• Market Breakout by Disease Treated (Cardiovascular, Hormones, Pain Management, Smoking Cessation, Other)
• Market Breakout by Technology Revenues and Pharmaceutical Component Revenues
• Profiles of Companies in the Market

The research conducted by Kalorama included comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and database searches, as well as via interviews with key personnel. Person-to-person and telephone interviews were the primary method of gathering information. E-mail correspondence was also used in the interview process. Interviews with 18 key industry officials, trade association representatives, consultants, healthcare providers, and government personnel were compiled to form the primary basis of information—particularly revenue and market share data—presented in this report.

All market data pertain to the worldwide market at the manufacturers’ level and presented in U.S. dollars. The base year for data was 2012. Historical data are provided for 2010 through 2011, with forecast data provided for 2013 through 2017. Compound annual growth rates (CAGR) are provided for the 2010-2012, 2012-2017, and 2010–2017 periods.

Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Market Drivers
Market Size and Growth
  Total Transdermal/Transmucosal Drug Delivery Market
  Transdermal/Transmucosal Drug Delivery Only Market
Competitive and Market Analysis

CHAPTER TWO: INTRODUCTION AND OVERVIEW

Scope and Methodology
Reasons for Transdermal/Transmucosal Drug Delivery Systems
Phases of Drug Action
Transdermal drug Delivery
  History of Transdermal Drug Delivery
  Advantages of Transdermal Drug Delivery
  Disadvantages of Transdermal Drug Delivery
  Transdermal Patch (Passive) Drug Delivery
  Transfersomes
  Medicated Tattoos
  Crystal Reservoir Technology
Active Transdermal Drug Applications
  Electrotransport Drug Delivery
  Iontophoresis
  Reverse Iontophoresis
  Sonophoresis
  Photomechanical Waves
Transmucosal Drug Delivery
  Buccal Drug Delivery
  Vaginal Drug Delivery

CHAPTER THREE: TRENDS AND DEVELOPMENTS

Novel Transdermal Approvals
Innovations in Transdermal Drug Delivery
Adhesive Technology and Issues
Adhesive Market Issues
Generic Transdermal Study Design Guidelines
Biotechnological Issues
Developments in Insulin Delivery
New Developments in Hormone Drug Delivery
New Mucosal/Buccal Delivery Systems
Other New Drug Delivery Systems
Microneedle-Assisted Transdermal Drug Delivery
Controlled Thermal Energy Technology
New Ultrasound Technology
  Transdermal Products in Development

CHAPTER FOUR: MARKET SIZE AND GROWTH

The Total Transdermal/Transmucosal Drug Delivery Market
Transdermal/Transmucosal Delivery Technology Only Market

CHAPTER FIVE: COMPETITIVE ANALYSIS

Competitive Landscape
  Emerging Participants
Market Analysis

CHAPTER SIX: COMPANY PROFILES

3M Pharmaceuticals
Access Pharmaceuticals, Inc.
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences
Aveva Drug Delivery Systems
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Labtec GmbH
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
NITTO DENKO CORPORATION
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
APPENDIX: COMPANY DIRECTORY

Table Of Exhibits

TABLE OF EXHIBITS

CHAPTER TWO: INTRODUCTION AND OVERVIEW
Table 2-2: Select Leading Transdermal Delivery-Based Products
CHAPTER THREE: TRENDS AND DEVELOPMENTS
Table 3-1: Selected Transdermal Products in Development
CHAPTER FOUR: MARKET SIZE AND GROWTH
Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2010-2017
Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2010-2017
Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmusal Drug Delivery Systems by Type 2010–2017
Figure 4-2: The Worldwide Market for Pharmaceuticals UtilizingTransdermal/Transmucosal Drug Delivery Systems Revenues by Type 2010–2017
Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies Market Share by Type 2010-2017
Figure 4-3: Transdermal Drug Delivery Market by Disease Treated (Cardiovascular, Hormones, Pain Management, Smoking Cessation, Other)
Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Region (United States, Europe, Japan, ROW) 2010–2017
Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2010-2017
Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017
Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017
Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2012
Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2017
CHAPTER FIVE: COMPETITIVE ANALYSIS
Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology